• AgaMatrix (Salem, New Hampshire) has introduced its second blood glucose meter, the WaveSense Jazz featuring no coding, large backlit digits for reading, and a number of advanced features designed to enable tighter control over blood glucose levels. The Jazz, like the company’s first meter, the KeyNote, is powered by WaveSense, a suite of technologies that enable high accuracy glucose monitoring products. WaveSense employs Dynamic Electrochemistry to extract a spectrum of information inaccessible to traditional static electrochemistry methods.

• Amnis (Seattle) has released two upgrades to its ImageStream system, including the commercial release of a multi-laser capability and the beta release of a new technology for dramatically extending the depth of field beyond conventional optical limitations. The Multilaser upgrade provides the flexibility of adding two additional lasers including a 405nm (violet) laser and a 658nm (red) laser. These lasers provide for increased experimental flexibility and sophistication by greatly expanding the fluorescent dye selection available to the customer. The upgrade is accompanied by an enhancement to the optical system which provides precise chromatic correction for lower wavelength dyes excited by the 405nm laser. The enhancement enables high resolution imagery resulting from fluorescence excitation from all three lasers to be captured simultaneously across the entire visible spectrum. Amnis manufactures the ImageStream system for high speed imaging of cells in flow. The ImageStream system enables scientists to conduct research in hematology, immunology and oncology.

• Clarient (Aliso Viejo, California) has released its next-generation of PATHSiTE, an internet-based flow cytometry program that enables pathologists, when evaluating their leukemia and lymphoma cases, to have complete control over the gating analysis on cell populations. Clarient launched its upgraded online tool through its partnership with De Novo Software. The PATHSiTE web-based portal connects pathologists to Clarient’s flow cytometry as well as the instrumentation and software technology needed to effectively analyze specimen data. Clarient is a technology and services resource for pathologists, oncologists and the pharmaceutical industry.

• Vital Images (Minneapolis, Minnesota) has released its next-generation visualization and analysis product solutions, Vitrea 4.0 and ViTALConnect 4.1, offering advanced visualization and analysis via workstation clients, remote clients and Web-based clients. The company also released ViTAL EP, a new electrophysiology (EP) planning application to augment its cardiovascular suite of products and Medicsight’s ColonCAD for its InnerviewGI virtual colonoscopy application. Enhancements to the company’s Vitrea 4.0 workstation-client release include cardiovascular workflow enhancements such as automatic segmentation and probing of the coronary tree, easier vessel management and labeling, easy centerline editing and comprehensive reporting with automatic population of findings. Neurovascular improvements include motion correction and simultaneous multi-slice computation for true 4-D perfusion for stroke patients. This release also includes improved colon enhancements such as fly-through capabilities, polyp probe and automatic registration of prone and supine, among other significant usability improvements including computer aided detection (CAD) designed to identify suspicious regions in the colon. Vital Images makes visualization and analysis solutions.

* VivoMetrics (Ventura, California) reported making enhancements to its LifeShirt preclinical system by incorporating Bluetooth wireless technology. The upgraded capabilities of the wireless technology deliver effortless, fast connections between the LifeShirt and data management systems that measure and quantify the research subject’s vital signs. LifeShirt technology has been used in clinical studies of human subjects and has proven to be a reliable and beneficial component of research. The LifeShirt preclinical system is the first non-invasive, real-time ambulatory monitoring system that continuously collects, records and analyzes a broad range of cardiopulmonary parameters. Designed specifically for the needs of the preclinical market, the system includes a lightweight, machine washable garment with embedded sensors that collect pulmonary, cardiac, posture and activity signals from freely moving subjects for up to 24 hours. Data generated is wirelessly transmitted and VivoSoftware allows researchers to monitor and analyze data of up to 16 subjects in real-time or to be stored for later analysis. VivoMetrics makes non-invasive products and services.